India’s IGPL plans new 80,000 tonne/year PA line

Priya Jestin

11-Feb-2021

MUMBAI (ICIS)–India’s IG Petrochemicals Ltd (IGPL) plans to set up a greenfield 80,000 tonnes/year phthalic anhydride (PA) plant in western Gujarat state, it said in a statement.

The company’s board of directors approved the setting up of the Indian rupees (Rs) 6bn ($82m) chemical complex at Gujarat which will contain the PA line and other derivative plants, it said in the filing on the Bombay Stock Exchange (BSE) on 9 February.

The new plant will commence operations in three years, the company said, adding that it planned to raise funds for the new project through internal accruals and loans.

The new PA capacity will help IG Petrochemicals meet increasing demand in downstream products like paints, plasticizers¸ polyvinyl chloride (PVC), unsaturated polyester resins etc, IGPL said in its statement.

“The demand for PA in the domestic market is expected to increase due to government focus on infrastructure spending and demand growth led by good GDP growth in India,” it added.

The company began commercial production at its 53,000 tonnes/year brownfield manufacturing facility (PA-4) at Taloja in western Maharashtra state on 29 December 2020.

Post expansion IGPL currently produces around 222,110 tonnes/year of PA, 8,000 tonnes/year of Maleic Anyhdride (MA) and 1,300 tonnes/year of benzoic acid and 8,400 tonnes/year of plasticizers at its Taloja complex as per the company website.

($1 = Rs 72.83)

READ MORE

Global News + ICIS Chemical Business (ICB)

See the full picture, with unlimited access to ICIS chemicals news across all markets and regions, plus ICB, the industry-leading magazine for the chemicals industry.

Contact us

Partnering with ICIS unlocks a vision of a future you can trust and achieve. We leverage our unrivalled network of industry experts to deliver a comprehensive market view based on independent and reliable data, insight and analytics.

Contact us to learn how we can support you as you transact today and plan for tomorrow.

READ MORE